Regeneron at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Regeneron takes part in 3 sessions at ESMO 2026 in Madrid, and exhibits at Booth 1017. Its program centres on skin cancer, from combining surgery, radiation and systemic therapy in cutaneous squamous cell carcinoma to the diagnosis, staging and treatment of early-stage melanoma. It also covers turning patient-reported outcomes into evidence that can be acted on.

OrganizationESMO 2026 Attendance
regeneron.com
Large pharmaExhibitor
US biotechnology company whose cancer medicines include the PD-1 antibody cemiplimab and bispecific antibodies for blood cancers.
Booth
Exhibiting at Booth 1017
Satellite
Sun Oct 25
13:00–14:30
Satellite
Sun Oct 25
18:30–20:00
Regeneron - From Voice to Value: Advancing Actionable Patient- Reported Outcomes Evidence in Oncology
Sponsored session · with Hospital Universitario Ramón y Cajal
Nursing & supportive care
Satellite
Sun Oct 25
18:30–20:00
Regeneron - Perspectives on Early-stage Melanoma: Diagnosis, Staging, and Treatment
Sponsored session · with University Hospital Schleswig-Holstein
Melanoma & skin cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Regeneron

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction